- Thoratec (NASDAQ:THOR-OLD -1.5%) Q2 results: Product Sales: $118.1M (-9.5%); Gross Profit: $83.8M (-6.4%); Operating Expenses: $58.5M (+3.7%); Operating Income: $25.2M (-23.6%); Net Income: $17.4M (-25.0%); EPS: $0.30 (-25.0%); Quick Assets: $291.2M (-4.8%).
- 2014 Guidance: Revenues: $455M - 470M; GAAP EPS: $0.80 - 0.90; non-GAAP EPS: $1.25 - 1.35.